Madjed, Jembran M.
HRN: 26-13-77 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/05/2026
CEFUROXIME 750MG (VIAL)
03/05/2026
03/11/2026
IV
220mg
Q8
PCAP C
Checking Initial Appropriateness
03/05/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
03/05/2026
03/11/2026
IV
100mg
Q24
PCAP C
Checking Initial Appropriateness